[go: up one dir, main page]

TNSN98176A1 - Compositions pharmaceutiques topiques contenant des derives de resorcinol - Google Patents

Compositions pharmaceutiques topiques contenant des derives de resorcinol

Info

Publication number
TNSN98176A1
TNSN98176A1 TNTNSN98176A TNSN98176A TNSN98176A1 TN SN98176 A1 TNSN98176 A1 TN SN98176A1 TN TNSN98176 A TNTNSN98176 A TN TNSN98176A TN SN98176 A TNSN98176 A TN SN98176A TN SN98176 A1 TNSN98176 A1 TN SN98176A1
Authority
TN
Tunisia
Prior art keywords
pharmaceutical compositions
compositions containing
topical pharmaceutical
resorcinol derivatives
containing resorcinol
Prior art date
Application number
TNTNSN98176A
Other languages
English (en)
Inventor
Hu Lan
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of TNSN98176A1 publication Critical patent/TNSN98176A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25—Silicon; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/915—Therapeutic or pharmaceutical composition
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/926—Topical chemical, e.g. cosmetic or sunscreen

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)

Abstract

L INVENTION CONCERNE UNE COMPOSITION PHARMACEUTIQUE COMPRENANT UN COMPOSE DE FORMULE 1 DANS LAQUELLE X REPRESENTE L HYDROGENE OU DIVERS RADICAUX , N VA DE 0 A 3 ET LA LIGNE DISCONTINUE INDIQUE UNE DOUBLE LIAISON FACULTATIVE ET UN SUPPORT PHARMACEUTIQUEMENT ACCEPTABLE , ELLE CONCERNE EGALEMENT UN PROCEDE POUR SA PREPARATION APPLICATION : UTILISATION DANS L ECLAIRCISSEMENT DE LA PEAU OU LA REDUCTION DE LA PIGMENTATION CUTANEE ,
TNTNSN98176A 1997-09-23 1998-09-22 Compositions pharmaceutiques topiques contenant des derives de resorcinol TNSN98176A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5962597P 1997-09-23 1997-09-23

Publications (1)

Publication Number Publication Date
TNSN98176A1 true TNSN98176A1 (fr) 2005-03-15

Family

ID=22024176

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN98176A TNSN98176A1 (fr) 1997-09-23 1998-09-22 Compositions pharmaceutiques topiques contenant des derives de resorcinol

Country Status (45)

Country Link
US (1) US6132740A (fr)
EP (1) EP0904774B1 (fr)
JP (2) JP3591763B2 (fr)
KR (1) KR100373996B1 (fr)
CN (1) CN1176647C (fr)
AP (1) AP857A (fr)
AR (1) AR012520A1 (fr)
AT (1) ATE235220T1 (fr)
AU (1) AU735716C (fr)
BG (1) BG64524B1 (fr)
BR (1) BR9803596A (fr)
CA (1) CA2247748C (fr)
CO (1) CO5070677A1 (fr)
CZ (1) CZ297669B6 (fr)
DE (1) DE69812519T2 (fr)
DK (1) DK0904774T3 (fr)
DZ (1) DZ2614A1 (fr)
EA (1) EA003576B1 (fr)
EG (1) EG23860A (fr)
ES (1) ES2192301T3 (fr)
GT (1) GT199800150A (fr)
HR (1) HRP20000168B1 (fr)
HU (1) HUP0003743A3 (fr)
ID (1) ID24084A (fr)
IL (2) IL134598A0 (fr)
IS (1) IS2280B (fr)
MA (1) MA26548A1 (fr)
MY (1) MY117805A (fr)
NO (1) NO327177B1 (fr)
NZ (1) NZ502797A (fr)
OA (1) OA11334A (fr)
PA (1) PA8459901A1 (fr)
PE (1) PE117299A1 (fr)
PL (1) PL195192B1 (fr)
PT (1) PT904774E (fr)
SA (1) SA98190724B1 (fr)
SI (1) SI0904774T1 (fr)
SK (1) SK284983B6 (fr)
TN (1) TNSN98176A1 (fr)
TR (1) TR200000782T2 (fr)
TW (1) TW585780B (fr)
UA (1) UA57106C2 (fr)
UY (2) UY25191A1 (fr)
WO (1) WO1999015148A1 (fr)
ZA (1) ZA988669B (fr)

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1996000101A (es) 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis
US6414037B1 (en) * 1998-01-09 2002-07-02 Pharmascience Pharmaceutical formulations of resveratrol and methods of use thereof
FR2777183B1 (fr) * 1998-04-10 2001-03-02 Oreal Utilisation d'au moins un hydroxystilbene dans une composition destinee a favoriser la desquamation de la peau et composition le comprenant
FR2777186B1 (fr) * 1998-04-10 2001-03-09 Oreal Utilisation d'au moins un hydroxystilbene dans une composition raffermissante
US6878381B2 (en) * 1999-03-22 2005-04-12 Pfizer, Inc Resorcinol composition
US6828460B2 (en) * 1999-03-22 2004-12-07 Pfizer Inc. Resorcinol derivatives
HN2000000033A (es) * 1999-03-22 2001-02-02 Pfizer Prod Inc Composicion de resorcinol
ES2238993T3 (es) * 1999-03-22 2005-09-16 Pfizer Inc. Derivados de resorcinol.
US20020034772A1 (en) * 1999-06-29 2002-03-21 Orlow Seth J. Methods and compositions that affect melanogenesis
EP1134207A1 (fr) * 2000-03-15 2001-09-19 Pfizer Products Inc. Procédé pour la préparation de dérivés du résorcinol
IT1318425B1 (it) * 2000-03-24 2003-08-25 D B P Dev Biotechnological Pro Impiego del resveratrolo per il trattamento di eczema desquamativo,acne e psoriasi.
JP4615671B2 (ja) * 2000-04-20 2011-01-19 ポーラ化成工業株式会社 炎症存在下使用用のしわ形成又は皮膚の弾力喪失の防止剤
EP1317425B1 (fr) * 2000-09-11 2004-11-03 Pfizer Products Inc. Derives de resorcinol
JP3950046B2 (ja) * 2000-09-21 2007-07-25 ファイザー・プロダクツ・インク レゾルシノール誘導体
US6514506B1 (en) * 2001-02-14 2003-02-04 Color Access, Inc. Whitening compositions containing ascomycete derived enzyme
MY134040A (en) 2001-05-02 2007-11-30 Univ New York Inhibition of pigmentation by inhibition of fatty acid synthase
CA2445647A1 (fr) * 2001-05-25 2002-12-05 P&G-Clairol, Inc. Derives de 1,3-dihydroxybenzene et colorants contenant ces composes
US6869598B2 (en) * 2002-03-22 2005-03-22 Unilever Home & Personal Care Usa Division Of Conopco, Inc. Stabilization of sunscreens in cosmetic compositions
US6863897B2 (en) * 2002-03-22 2005-03-08 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Stabilization of resorcinol derivatives in cosmetic compositions
US7378232B2 (en) * 2002-05-09 2008-05-27 New York University Assay for melanogenesis
US7977049B2 (en) * 2002-08-09 2011-07-12 President And Fellows Of Harvard College Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
US6852310B2 (en) * 2002-08-23 2005-02-08 Unilever Home & Personal Care Usa Division Of Conopco, Inc. Skin lightening agents, compositions and methods
US20040109832A1 (en) * 2002-12-09 2004-06-10 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Di-substituted resorcinols as skin lightening agents
US7524485B2 (en) * 2002-12-12 2009-04-28 Unilever Home & Personal Care, Usa, Division Of Conopco, Inc. Skin lightening agents, compositions and methods
US6875425B2 (en) * 2002-12-12 2005-04-05 Unilever Home & Personal Care Usa Skin lightening agents, compositions and methods
CA2513949A1 (fr) * 2003-02-03 2004-08-19 Warner-Lambert Company Llc Formulation amelioree d'agents eclaircissant de la peau
US7338979B2 (en) * 2003-02-11 2008-03-04 Warner-Lambert Company Depigmentation agents
MXPA05012500A (es) * 2003-05-20 2006-01-30 Warner Lambert Co Agentes depigmentantes.
US20070009455A1 (en) * 2003-05-26 2007-01-11 Hyo-Jung Kim Whitening and antionxidative cosmetic composition containing resveratrol and method for preparing the same
EP2236131A3 (fr) 2003-07-01 2011-03-02 President and Fellows of Harvard College Modulateurs de SIRT1 pour la manipulation de la durée de vie et de la réaction de stress de cellules et d'organismes
WO2005005355A1 (fr) * 2003-07-08 2005-01-20 Unilever Plc Procede de preparation d'un principe actif cosmetique
US8017634B2 (en) 2003-12-29 2011-09-13 President And Fellows Of Harvard College Compositions for treating obesity and insulin resistance disorders
CA2548671C (fr) 2003-12-29 2015-02-24 President And Fellows Of Harvard College Compositions pour traiter ou prevenir l'obesite et les troubles de resistance a l'insuline
US7300646B2 (en) * 2004-02-27 2007-11-27 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Skin lightening agents, compositions and methods
WO2005117849A1 (fr) 2004-05-28 2005-12-15 Unigen Pharmaceuticals, Inc. Diarylalcanes constituant des inhibiteurs puissants d'enzymes binucleaires
JP2008513378A (ja) * 2004-09-14 2008-05-01 アジノモト オムニケム エッス．アー． リン酸化ポリフェノールを含有する局所組成物
JP5093998B2 (ja) * 2004-09-22 2012-12-12 大塚製薬株式会社 色素沈着予防又は改善剤
US20060210498A1 (en) * 2005-03-18 2006-09-21 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Novel resorcinol derivatives for skin
US20060210497A1 (en) * 2005-03-18 2006-09-21 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Novel resorcinol derivatives
WO2006138418A2 (fr) 2005-06-14 2006-12-28 President And Fellows Of Harvard College Amelioration de la performance cognitive avec des activateurs de sirtuine
JP5244400B2 (ja) * 2005-12-26 2013-07-24 株式会社林原 アルキルレゾルシノール配糖体とその製造方法並びに用途
JP2009522337A (ja) * 2006-01-05 2009-06-11 シムライズ・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング・ウント・コンパニー・コマンジツト・ゲゼルシヤフト ジフェニルメタン誘導体並びにさらなる皮膚及び／又は毛髪ライトニング及び／又は老人性角化症軽減化合物を含む相乗活性製剤
US7270805B1 (en) 2006-03-30 2007-09-18 Conopco, Inc. Skin lightening agents, compositions and methods
US7247294B1 (en) 2006-03-30 2007-07-24 Conopco, Inc. Skin lightening agents, compositions and methods
US7250158B1 (en) 2006-03-30 2007-07-31 Conopco, Inc. Skin lightening agents, compositions and methods
KR101361430B1 (ko) * 2006-06-19 2014-02-10 가부시키가이샤 구라레 안정성이 우수한 피부 외용제
JP5132095B2 (ja) * 2006-07-13 2013-01-30 ポーラ化成工業株式会社 エマルション剤形の皮膚外用剤
JP4990574B2 (ja) * 2006-07-13 2012-08-01 ポーラ化成工業株式会社 新規化合物及びそれを含有する皮膚外用剤
DE102007038097A1 (de) 2007-08-13 2009-02-19 Merck Patent Gmbh Tyrosinaseinhibitoren
DE102007038098A1 (de) 2007-08-13 2009-02-19 Merck Patent Gmbh Tyrosinaseinhibitoren
WO2009064492A1 (fr) * 2007-11-14 2009-05-22 New York University School Of Medicine Composés de quinoline à titre de modificateurs de mélanogenèse et leurs utilisations
WO2009064493A1 (fr) * 2007-11-14 2009-05-22 New York University School Of Medicine Composés tricycliques en tant que modificateurs de la mélanogenèse et leurs utilisations
US20100040568A1 (en) * 2008-04-30 2010-02-18 Skinmedica, Inc. Steroidal compounds as melanogenesis modifiers and uses thereof
US20100010100A1 (en) * 2008-07-09 2010-01-14 Hinman Andrew W Dermatological compositions with anti-aging and skin even-toning properties
KR101988329B1 (ko) * 2008-07-21 2019-06-12 유니젠, 인크. 일련의 피부-화이트닝(라이트닝) 화합물
US20100029784A1 (en) * 2008-07-30 2010-02-04 Hinman Andrew W Naphthoquinone compositions with anti-aging, anti-inflammatory and skin even-toning properties
FR2939135B1 (fr) 2008-12-02 2010-12-03 Galderma Res & Dev Nouveaux composes 4-(azacycloalkyl)-benzene-1,3-diol comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
FR2939136B1 (fr) 2008-12-02 2010-12-03 Galderma Res & Dev Nouveaux composes 4-(heterocycloalkyl)-benzene-1,3-diol comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
FR2953834B1 (fr) 2009-12-10 2012-01-13 Galderma Res & Dev Nouveaux composes 4-(azacycloalkyl)-benzene-1,3-diol comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
JP4825921B1 (ja) * 2010-07-16 2011-11-30 株式会社 資生堂 ４−アルキルレゾルシノール誘導体及びこれを含有する皮膚外用剤
US8772252B2 (en) 2011-01-27 2014-07-08 New York University Coumarin compounds as melanogenesis modifiers and uses thereof
BR112013024413B1 (pt) 2011-03-24 2020-02-18 Unigen, Inc. Compostos e métodos para a preparação de diarilpropanos
CA3167320A1 (fr) 2013-03-08 2014-09-12 Unilever Global Ip Limited Composes resorcinols pour un usage dermatologique
RU2582215C1 (ru) * 2015-01-16 2016-04-20 Александр Ливиевич Ураков Способ обесцвечивания кожи в области кровоподтека
WO2017079905A1 (fr) * 2015-11-10 2017-05-18 Henkel Ag & Co. Kgaa Composition cosmétique pour l'éclaircissement de la peau
JP7009392B2 (ja) 2016-06-15 2022-01-25 ユニリーバー・アイピー・ホールディングス・ベー・フェー アルキル置換レゾルシノールの経皮送達促進のための方法及び化粧品組成物
WO2018001485A1 (fr) * 2016-06-30 2018-01-04 Symrise Ag Médicament et composition cosmétique comprenant des dérivés de résorcinol
CA3069345A1 (fr) * 2017-07-12 2019-01-17 Unilever Plc Huile de renforcement pour composition de soin de la peau
IT201700104536A1 (it) 2017-09-19 2019-03-19 Cmed Aesthetics Srl Prodotti topici con sistema bifasico
US20220362120A1 (en) 2019-07-12 2022-11-17 Conopco, Inc., D/B/A Unilever Stabilization of resorcinol compounds in cosmetic compositions
US20220395440A1 (en) * 2019-10-30 2022-12-15 Dow Global Technologies Llc Sun care compositions with hollow mesoporous silica nanospheres
EP4142680B1 (fr) 2020-04-28 2023-10-18 Unilever IP Holdings B.V. Compositions cosmétiques stabilisées comprenant de la cystine de n, n'-diacetyle
CN114315527B (zh) * 2021-12-29 2024-06-11 苏州博研医药科技有限公司 一种间苯二酚的制备方法
CN120826212A (zh) 2022-12-21 2025-10-21 联合利华知识产权控股有限公司 具有吲哚的配方的颜色稳定化
WO2025140839A1 (fr) 2023-12-29 2025-07-03 Unilever Ip Holdings B.V. Stabilisation de couleur de formules avec du nitrure de bore
WO2025225705A1 (fr) * 2024-04-25 2025-10-30 国立大学法人富山大学 Promoteur de décomposition de mélanine et inhibiteur de production de mélanine

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1131200A (en) * 1966-06-06 1968-10-23 Fuji Photo Film Co Ltd Process for the production of polymer images by the polymerization of vinyl compounds
FR1574759A (fr) * 1967-04-06 1969-07-18
US3933925A (en) * 1972-06-29 1976-01-20 Koppers Company, Inc. Hydrolysis of toluene diamines to produce methyl resorcinols
US4006218A (en) * 1974-07-08 1977-02-01 Johnson & Johnson Potentiated medicaments
DE2616479C2 (de) * 1976-04-14 1986-12-04 Brickl, Rolf, Dr., 7951 Warthausen Substituierte Fluoracylresorcine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel und Kosmetika
DE3127590A1 (de) * 1980-07-12 1982-08-12 Kozak, Pavel, 6600 Saarbrücken Mittel fuer die externe behandlung von hautkrakheiten
US4391827A (en) * 1980-09-08 1983-07-05 Pfizer Inc. 3-(2-Hydroxy-4-(substituted)phenyl)-cycloalkanone and cycloalkanol analgesic agents and intermediates therefor
US4526179A (en) * 1983-01-28 1985-07-02 Leonard Salesky Digital apical foramen locating apparatus
DE3604865A1 (de) * 1986-02-15 1987-08-20 Walter Dr Med Langbehn Haut-kosmetikum
JPH0651619B2 (ja) * 1988-05-09 1994-07-06 株式会社クラレ 美白剤
US4985157A (en) * 1989-05-01 1991-01-15 Mobil Oil Corporation Mixed alkoxylated alcohol-hydroquinone/resorcinol borates-antioxidants
US5059438A (en) * 1990-02-05 1991-10-22 Enzytech, Inc. Compositions and methods for inhibiting browning in foods using resorcinol derivatives
JP2875374B2 (ja) * 1990-10-31 1999-03-31 ポーラ化成工業株式会社 ニキビ用化粧料
JP2801960B2 (ja) * 1990-10-31 1998-09-21 ポーラ化成工業株式会社 頭髪化粧料
JPH054905A (ja) * 1990-10-31 1993-01-14 Pola Chem Ind Inc 化粧料
FR2679133B1 (fr) * 1991-07-17 1993-10-15 Oreal Utilisation de derives d'acides (2,5-dihydroxyphenyl)carboxyliques, leurs homologues et leurs sels dans la preparation d'une composition cosmetique ou dermatologique a action depigmentante.
EP0524439A1 (fr) * 1991-07-24 1993-01-27 F.Hoffmann-La Roche & Co. Aktiengesellschaft Dérivés du cyclohexane et du tétrahydropyranne et compositions antifongiques contenant ces dérivés
SK280617B6 (sk) * 1992-01-16 2000-05-16 Hoechst Aktiengesellschaft Arylcykloalkylové deriváty, spôsob ich prípravy, f
CA2094465A1 (fr) * 1992-04-23 1993-10-24 Pierre Andre Raymond Bruneau Derives de cycloalcane
JPH0656641A (ja) * 1992-08-05 1994-03-01 Nippon Paint Co Ltd 化粧料
US5399785A (en) * 1992-08-05 1995-03-21 Nippon Paint Co., Ltd. Tyrosinase activity inhibitor
FR2704428B1 (fr) * 1993-04-29 1995-06-09 Oreal Utilisation de dérivés de la résorcine substitués en position(s) 4, 4 et 5 ou 4 et 6 dans des compositions cosmétiques ou dermopharmaceutiques à action dépigmentante.
FR2704753B1 (fr) * 1993-05-06 1995-06-30 Oreal Utilisation de derives de la 4-thio resorcine ou 4-thio 1-3-dihydroxybenzene, dans des compositions cosmetiques ou dermopharmaceutiques a action depigmentante.
GB9418762D0 (en) * 1994-09-16 1994-11-02 Bayer Ag Use of substituted cyclopentane-DI-and-triones
JP2790986B2 (ja) * 1995-02-27 1998-08-27 住友建設株式会社 橋脚の構築方法及び施工方法

Also Published As

Publication number Publication date
EG23860A (en) 2007-11-18
AP857A (en) 2000-07-11
CN1270509A (zh) 2000-10-18
UY25550A1 (es) 2000-02-23
KR100373996B1 (ko) 2003-02-26
US6132740A (en) 2000-10-17
TW585780B (en) 2004-05-01
HK1028344A1 (en) 2001-02-16
BG64524B1 (bg) 2005-06-30
BR9803596A (pt) 2000-04-25
DZ2614A1 (fr) 2003-03-01
IS5376A (is) 2000-02-15
ES2192301T3 (es) 2003-10-01
EP0904774A1 (fr) 1999-03-31
CA2247748A1 (fr) 1999-03-23
ID24084A (id) 2000-07-06
CA2247748C (fr) 2002-07-02
HRP20000168B1 (en) 2006-07-31
OA11334A (en) 2003-12-10
AP9801349A0 (en) 1998-09-30
NO20001473D0 (no) 2000-03-22
GT199800150A (es) 2000-03-15
NZ502797A (en) 2002-04-26
AR012520A1 (es) 2000-10-18
ZA988669B (en) 2000-03-22
NO20001473L (no) 2000-03-22
MY117805A (en) 2004-08-30
CO5070677A1 (es) 2001-08-28
DK0904774T3 (da) 2003-06-16
SI0904774T1 (en) 2003-10-31
UY25191A1 (es) 2001-08-27
AU8994698A (en) 1999-04-12
PA8459901A1 (es) 2000-05-24
CZ20001037A3 (cs) 2001-02-14
SA98190724B1 (ar) 2006-05-20
JP2004210799A (ja) 2004-07-29
HRP20000168A2 (en) 2000-08-31
IL170545A (en) 2010-04-29
UA57106C2 (uk) 2003-06-16
JP3591763B2 (ja) 2004-11-24
HUP0003743A2 (hu) 2001-04-28
EA200000251A1 (ru) 2000-08-28
PL339551A1 (en) 2000-12-18
PE117299A1 (es) 1999-11-18
TR200000782T2 (tr) 2000-09-21
CN1176647C (zh) 2004-11-24
JPH11152203A (ja) 1999-06-08
KR20010024217A (ko) 2001-03-26
SK284983B6 (sk) 2006-03-02
WO1999015148A1 (fr) 1999-04-01
CZ297669B6 (cs) 2007-02-28
EP0904774B1 (fr) 2003-03-26
DE69812519D1 (de) 2003-04-30
ATE235220T1 (de) 2003-04-15
IL134598A0 (en) 2001-04-30
PL195192B1 (pl) 2007-08-31
MA26548A1 (fr) 2004-12-20
PT904774E (pt) 2003-08-29
AU735716B2 (en) 2001-07-12
HUP0003743A3 (en) 2006-02-28
BG104247A (en) 2000-11-30
IS2280B (is) 2007-09-15
SK3782000A3 (en) 2001-06-11
DE69812519T2 (de) 2003-12-11
EA003576B1 (ru) 2003-06-26
AU735716C (en) 2007-03-29
NO327177B1 (no) 2009-05-04

Similar Documents

Publication Publication Date Title
TNSN98176A1 (fr) Compositions pharmaceutiques topiques contenant des derives de resorcinol
TNSN00231A1 (fr) Forme cristalline de 4-carboxyamino-2-substitue-1,2,3,4- tetrahydroquinoleine, et compositions la contenant
CA2191789A1 (fr) Composes biaromatiques portant un groupement adamantyl en ortho, compositions pharmaceutiques et cosmetiques les contenant et utilisations de ces compositions
TNSN99252A1 (fr) Composes nouveaux modulateurs de chimiokine ccr5 et compositions pharmaceutiques les contenant.
CA2268097A1 (fr) Derives d'acide sulfinique, leur production et leur utilisation
CA2224528A1 (fr) Composes stilbeniques a groupement adamantyl, compositions les contenant et utilisations
TNSN98104A1 (fr) Agonistes de prostaglandines, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN99171A1 (fr) 4-carboxyamino-2-substitue-1,2,3,4-tetrahydroquinoleines, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN00232A1 (fr) Derives de 2,4-diaminopyrimidine nouveaux, et compositions les contenant
TNSN99142A1 (fr) Derives de benzimidazole nouveaux, compositions pharmaceutiques les contenant et procede pour leur preparation.
TNSN99172A1 (fr) 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinoleines, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN01048A1 (fr) Acides malonamiques et leurs derives, et compositions les contenant
CA2227967A1 (fr) Compositions topiques pour application locale a contact cutane plus confortable
TNSN01035A1 (fr) Derives d'ethers de pyrazole nouveaux, et compositions pharmaceutiques les contenant.
NZ512883A (en) 2-oxoquinoline compounds and medicinal uses thereof
TNSN99001A1 (fr) Indoles 2,3-substitues servant d'agents anti-inflammatoires et analgesiques
YU21701A (sh) Farmaceutska sredstva za lečenje parkinsonove bolesti, poremećaja nekontrolisane hiperaktivnosti (adhd) i mikroadenoma
CA2191790A1 (fr) Composes biaromatiques portant un groupement adamantyl en para, compositions pharmaceutiques et cosmetiques les contenant et utilisations de ces compositions
TNSN00054A1 (fr) Derives de resorcinol, compositions pharmaceutiques les contenant et procede pour leur preparation
HUP9801924A2 (hu) Nátrium/hidrogén-csere inhibitorokat és szív- és keringési zavarok kezelésére alkalmas hatóanyagokat tartalmazó gyógyszerkészítmény
CA2099473A1 (fr) Composition cosmetique et/ou dermatologique a action depigmentante contenant un acide di- ou tri-cafeoylquinique ou un melange de ceux-ci
TNSN97156A1 (fr) Derives de pyrrolidinyl-et pyrrolinyl-ethylamine, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN99221A1 (fr) Derive d'indole nouveau, procede pour sa preparation et compositions pharmaceutiques le contenant
TNSN00055A1 (fr) Composition pharmaceutique de resorcinol, et procede pour sa preparation
CA2210365A1 (fr) Nouveau derive de l'acide kojique et son utilisation comme agent depigmentant